These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24369461)

  • 1. Blood glucose control using a novel continuous blood glucose monitor and repetitive intravenous insulin boluses: exploiting natural insulin pulsatility as a principle for a future artificial pancreas.
    Skjaervold NK; Ostling D; Hjelme DR; Spigset O; Lyng O; Aadahl P
    Int J Endocrinol; 2013; 2013():245152. PubMed ID: 24369461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of intravenous insulin administration: implications for future closed-loop glycemic control by the intravenous/intravenous route.
    Skjaervold NK; Lyng O; Spigset O; Aadahl P
    Diabetes Technol Ther; 2012 Jan; 14(1):23-9. PubMed ID: 21751892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closed-loop glycaemic control using an implantable artificial pancreas in diabetic domestic pig (Sus scrofa domesticus).
    Taylor MJ; Gregory R; Tomlins P; Jacob D; Hubble J; Sahota TS
    Int J Pharm; 2016 Mar; 500(1-2):371-8. PubMed ID: 26691655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas.
    Renard E; Place J; Cantwell M; Chevassus H; Palerm CC
    Diabetes Care; 2010 Jan; 33(1):121-7. PubMed ID: 19846796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance.
    Ritzel R; Schulte M; Pørksen N; Nauck MS; Holst JJ; Juhl C; März W; Schmitz O; Schmiegel WH; Nauck MA
    Diabetes; 2001 Apr; 50(4):776-84. PubMed ID: 11289042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration.
    Updike SJ; Shults MC; Gilligan BJ; Rhodes RK
    Diabetes Care; 2000 Feb; 23(2):208-14. PubMed ID: 10868833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The artificial pancreas: evaluating risk of hypoglycaemia following errors that can be expected with prolonged at-home use.
    Wolpert H; Kavanagh M; Atakov-Castillo A; Steil GM
    Diabet Med; 2016 Feb; 33(2):235-42. PubMed ID: 26036309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses.
    Sánchez-Peña R; Colmegna P; Garelli F; De Battista H; García-Violini D; Moscoso-Vásquez M; Rosales N; Fushimi E; Campos-Náñez E; Breton M; Beruto V; Scibona P; Rodriguez C; Giunta J; Simonovich V; Belloso WH; Cherñavvsky D; Grosembacher L
    J Diabetes Sci Technol; 2018 Sep; 12(5):914-925. PubMed ID: 29998754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsatile intravenous insulin replacement in streptozotocin diabetic rats is more efficient than continuous delivery: effects on glycaemic control, insulin-mediated glucose metabolism and lipolysis.
    Koopmans SJ; Sips HC; Krans HM; Radder JK
    Diabetologia; 1996 Apr; 39(4):391-400. PubMed ID: 8777988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid restoration of normoglycaemia using intravenous insulin boluses.
    Dunnett JM; Steemson J; Sear JW; Turner RC; Holman RR
    Diabetes Res; 1990 Dec; 15(4):151-5. PubMed ID: 2132403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices.
    Jørgensen JO; Møller N; Lauritzen T; Christiansen JS
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1616-23. PubMed ID: 2189886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal insulin administration in pigs: effect on circulating insulin and glucose levels.
    Dirnena-Fusini I; Åm MK; Fougner AL; Carlsen SM; Christiansen SC
    BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33452058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.
    Radermecker RP; Fayolle C; Brun JF; Bringer J; Renard E
    Diabetes Metab; 2013 May; 39(3):258-62. PubMed ID: 23522730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a highly responsive needle-type glucose sensor using polyimide for a wearable artificial endocrine pancreas.
    Ichimori S; Nishida K; Shimoda S; Sekigami T; Matsuo Y; Ichinose K; Shichiri M; Sakakida M; Araki E
    J Artif Organs; 2006; 9(2):105-13. PubMed ID: 16807813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
    Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
    J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes.
    Schaller HC; Schaupp L; Bodenlenz M; Wilinska ME; Chassin LJ; Wach P; Vering T; Hovorka R; Pieber TR
    Diabet Med; 2006 Jan; 23(1):90-3. PubMed ID: 16409572
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.